Zusammenfassung
Das Endometriumkarzinom ist ein häufiger Tumor mit vielen histopathologischen Varianten. Die meisten Fälle werden als Typ-I-Tumoren klassifiziert, zeigen eine endometrioide Morphologie, sind von niedrigem Grad und Stadium, und die Fünfjahresüberlebensrate ist ausgezeichnet. Typ-II-Tumoren sind viel seltener, es handelt sich hauptsächlich um seröse Karzinome, und die Typ-II-Tumoren sind ohne Ausnahme hoch aggressiv. Die klinische Zweiteilung zeigt sich auch anhand der reproduzierbaren molekulargenetischen Alterationen, die für jeden Typ spezifisch sind. Über die den Typ-II-Tumoren zugrunde liegenden Genmutationen ist weniger bekannt, und es bleibt abzuwarten, ob die Klarzellkarzinome des Endometriums als Typ I oder II eingestuft werden können oder ob sie sich dieser Klassifikation weiterhin entziehen.
Abstract
Endometrial carcinoma is a common malignancy with numerous histopathologic variants. The majority of cases are classified as type I tumors, show endometrioid morphology, are low grade and low stage and have excellent 5-year survival. Type II tumors are much less common, are predominantly serous carcinomas and are uniformly highly aggressive. This clinical dichotomy is reflected in and supported by reproducible molecular genetic alterations specific to each type. Less is known about the underlying genetic mutations for the rarer type II tumors and it is yet to be determined if clear cell carcinoma of the endometrium will be classifiable as type I, type II or will remain an outlier in this classification.
This is a preview of subscription content, access via your institution.


Literatur
Bokhman JV (1983) Two pathogenetic types of endometrial carcinoma. Gynecol Oncol 15:10–17
Lax SF (2004) Molecular genetic pathways in various types of endometrial carcinoma: from a phenotypical to a molecular-based classification. Virchows Arch 444:213–223
Baak JP, Kurver PH, Diegenbach PC et al (1981) Discrimination of hyperplasia and carcinoma of the endometrium by quantitative microscopy – a feasibility study. Histopathology 5:61–68
Mutter GL (2000) Endometrial intraepithelial neoplasia (EIN): will it bring order to chaos? The Endometrial Collaborative Group. Gynecol Oncol 76:287–290
Mutter GL, Zaino RJ, Baak JP et al (2007) Benign endometrial hyperplasia sequence and endometrial intraepithelial neoplasia. Int J Gynecol Pathol 26:103–114
Lacey JV Jr, Mutter GL, Nucci MR et al (2008) Risk of subsequent endometrial carcinoma associated with endometrial intraepithelial neoplasia classification of endometrial biopsies. Cancer 113:2073–2081
Pecorelli S (2009) Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. Int J Gynaecol Obstet 105:103–104
Silverberg S, Kurman RJ, Nogales F et al (2003) Tumours of the uterine corpus. Epithelial tumours and related lesions. In: Tavassoli F, Devilee P (eds) World Health Organization Classification of tumours, pathology and genetics of tumours of the breast and female genital organs. IARC Press, Lyon
Benedet JL, Bender H, Jones H III et al (2000) FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers. FIGO Committee on Gynecologic Oncology. Int J Gynaecol Obstet 70:209–262
Mutter GL, Lin MC, Fitzgerald JT et al (2000) Altered PTEN expression as a diagnostic marker for the earliest endometrial precancers. J Natl Cancer Inst 92:924–930
Levine RL, Cargile CB, Blazes MS et al (1998) PTEN mutations and microsatellite instability in complex atypical hyperplasia, a precursor lesion to uterine endometrioid carcinoma. Cancer Res 58:3254–3258
Maxwell GL, Risinger JI, Gumbs C et al (1998) Mutation of the PTEN tumor suppressor gene in endometrial hyperplasias. Cancer Res 58:2500–2503
Yoshinaga K, Sasano H, Furukawa T et al (1998) The PTEN, BAX, and IGFIIR genes are mutated in endometrial atypical hyperplasia. Jpn J Cancer Res 89:985–990
Ambros RA, Sherman ME, Zahn CM et al (1995) Endometrial intraepithelial carcinoma: a distinctive lesion specifically associated with tumors displaying serous differentiation. Hum Pathol 26:1260–1267
Sherman ME, Bitterman P, Rosenshein NB et al (1992) Uterine serous carcinoma. A morphologically diverse neoplasm with unifying clinicopathologic features. Am J Surg Pathol 16:600–610
Sherman ME, Bur ME, Kurman RJ (1995) p53 in endometrial cancer and its putative precursors: evidence for diverse pathways of tumorigenesis. Hum Pathol 26:1268–1274
Tashiro H, Isacson C, Levine R et al (1997) p53 gene mutations are common in uterine serous carcinoma and occur early in their pathogenesis. Am J Pathol 150:177–185
Jia L, Liu Y, Yi X et al (2008) Endometrial glandular dysplasia with frequent p53 gene mutation: a genetic evidence supporting its precancer nature for endometrial serous carcinoma. Clin Cancer Res 14:2263–2269
Liang SX, Chambers SK, Cheng L et al (2004) Endometrial glandular dysplasia: a putative precursor lesion of uterine papillary serous carcinoma. Part II: molecular features. Int J Surg Pathol 12:319–331
Zheng W, Liang SX, Yu H et al (2004) Endometrial glandular dysplasia: a newly defined precursor lesion of uterine papillary serous carcinoma. Part I: morphologic features. Int J Surg Pathol 12:207–223
Silva EG, Deavers MT, Bodurka DC et al (2006) Association of low-grade endometrioid carcinoma of the uterus and ovary with undifferentiated carcinoma: a new type of dedifferentiated carcinoma? Int J Gynecol Pathol 25:52–58
Silva EG, Deavers MT, Malpica A (2007) Undifferentiated carcinoma of the endometrium: a review. Pathology 39:134–138
George E, Lillemoe TJ, Twiggs LB et al (1995) Malignant mixed mullerian tumor versus high-grade endometrial carcinoma and aggressive variants of endometrial carcinoma: a comparative analysis of survival. Int J Gynecol Pathol 14:39–44
Ferguson SE, Tornos C, Hummer A et al (2007) Prognostic features of surgical stage I uterine carcinosarcoma. Am J Surg Pathol 31:1653–1661
Interessenkonflikt
Der korrespondierende Autor gibt an, dass kein Interessenkonflikt besteht.
Author information
Authors and Affiliations
Corresponding author
Zusatzmaterial online
Rights and permissions
About this article
Cite this article
Kurman, R., McConnell, T. Histopathologie des Endometriumkarzinoms. Onkologe 15, 1239–1242 (2009). https://doi.org/10.1007/s00761-009-1728-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00761-009-1728-7